Frank Rimerman Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$761K Sell
9,725
-4,640
-32% -$374K 0.04% 314
2026
Q1
$1.24M Buy
14,365
+1,274
+10% +$122K 0.08% 199
2025
Q4
$1.26M Buy
13,091
+766
+6% +$74.4K 0.08% 195
2025
Q3
$1.17M Buy
12,325
+2,784
+29% +$256K 0.08% 207
2025
Q2
$832K Buy
9,541
+2,247
+31% +$191K 0.06% 246
2025
Q1
$655K Buy
7,294
+3,316
+83% +$297K 0.05% 263
2024
Q4
$318K Sell
3,978
-11,805
-75% -$1.02M 0.02% 396
2024
Q3
$1.42M Sell
15,783
-6,629
-30% -$558K 0.1% 164
2024
Q2
$1.76M Buy
22,412
+22,064
+6,340% +$1.81M 0.12% 130
2024
Q1
$30.3K Buy
+348
New +$29.7K 0.01% 139

Other funds holding MDT

Frank Rimerman Advisors's MDT Position: Q2 2026 in Review

Frank Rimerman Advisors reduced its Medtronic (MDT) stake by 32% in Q2 2026, selling an estimated $374K and leaving 9,725 shares worth $761K. The position accounts for 0.04% of the portfolio, ranked #314.

Frank Rimerman Advisors first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.76M in Q2 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Frank Rimerman Advisors held 9,725 shares of Medtronic worth $761K as of Q2 2026.
  • Frank Rimerman Advisors sold 4,640 Medtronic shares in Q2 2026, an estimated $374K.
  • Medtronic made up 0.04% of Frank Rimerman Advisors's portfolio in Q2 2026, its #314 holding.
  • Frank Rimerman Advisors first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • Frank Rimerman Advisors's Medtronic position peaked at $1.76M in Q2 2024.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.